Ischemic heart diseases: current treatments and future
D Choi, KC Hwang, KY Lee, YH Kim - Journal of Controlled Release, 2009 - Elsevier
Ischemic heart disease is a rapidly increasing common cause of death in the world. This
disease is the insufficient status of oxygen within the cardiac muscles due to an imbalance …
disease is the insufficient status of oxygen within the cardiac muscles due to an imbalance …
Genomic changes in regenerated porcine coronary arterial endothelial cells
MYK Lee, HF Tse, CW Siu, SG Zhu… - … , and vascular biology, 2007 - Am Heart Assoc
Objective—Genomic changes were defined in cultures of regenerated porcine coronary
endothelial cells to explain the alterations that underlie their dysfunction. Methods and …
endothelial cells to explain the alterations that underlie their dysfunction. Methods and …
The future of drug eluting stents
RR Anis, KR Karsch - Heart, 2006 - heart.bmj.com
In-stent restenosis (ISR) is the major drawback of percutaneous coronary interventions,
occurring in 10–40% of patients. Drug eluting stents (DES) are successful in a large majority …
occurring in 10–40% of patients. Drug eluting stents (DES) are successful in a large majority …
Cost comparison of four revascularisation procedures for the treatment of multivessel coronary artery disease
X Wang, M Rokoss, A Dyub, A Gafni… - Journal of medical …, 2008 - Taylor & Francis
Objective: An economic evaluation was performed, using modelling techniques, to compare
1-year total costs of four revascularisation procedures in patients with multivessel disease …
1-year total costs of four revascularisation procedures in patients with multivessel disease …
[HTML][HTML] Modulating the release kinetics of paclitaxel from membrane-covered stents using different loading strategies
G Sydow-Plum, ZS Haidar, Y Merhi, M Tabrizian - Materials, 2008 - mdpi.com
Membrane-covered Express2TM Monorail® stents composed of chitosan (CH) blended with
polyethylene oxide (PEO) in 70: 30% wt (CH-PEO) were coated with a monolayer of …
polyethylene oxide (PEO) in 70: 30% wt (CH-PEO) were coated with a monolayer of …
An in vitro arterial model for testing cardiovascular drugs
S Chaterji - 2009 - search.proquest.com
Cardiovascular drug-eluting stents (DESs) have been used to prevent restenosis occurring
after the implantation of bare metal stents (BMSs). Recent studies, however, have indicated …
after the implantation of bare metal stents (BMSs). Recent studies, however, have indicated …
[PDF][PDF] Avaliação Económica dos Stents Medicados em Angioplastia Coronária [101]
R SANTOS, H PEREIRA - Rev Port Cardiol, 2005 - researchgate.net
RESUMO A angioplastia coronária revolucionou o tratamento da doença coronária, desde a
primeira angioplastia de balão até aos stents medicados, que surgiram como uma forma de …
primeira angioplastia de balão até aos stents medicados, que surgiram como uma forma de …
[CITATION][C] Эффективность реваскуляризации миокарда у больных стабильной стенокардией в сочетании с сахарным диабетом 2-го типа
СП Дезорцева - 2006 - elibrary.ru